The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $33.00

Today's change+0.24 +0.73%
Updated March 27 1:27 PM EDT. Delayed by at least 15 minutes.
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $33.00

Today's change+0.24 +0.73%
Updated March 27 1:27 PM EDT. Delayed by at least 15 minutes.

Teva Pharmaceutical Industries Ltd up (U.S.)$0.24

Teva Pharmaceutical Industries Ltd is up today by (U.S.)$0.24 or 0.73% to (U.S.)$33.00. Over the last five days, shares have lost 1.76% and sit 3.45% above their 52-week low. This security has underperformed the S&P 500 by 54.20% during the last year.

Key company metrics

  • Open(U.S.) $32.36
  • Previous close(U.S.) $32.76
  • High(U.S.) $33.19
  • Low(U.S.) $32.26
  • Bid / Ask(U.S.) $32.99 / (U.S.) $33.00
  • YTD % change-8.97%
  • Volume3,573,981
  • Average volume (10-day)5,574,440
  • Average volume (1-month)9,020,407
  • Average volume (3-month)10,052,471
  • 52-week range(U.S.) $31.90 to (U.S.) $58.16
  • Beta0.64
  • Trailing P/E213.01×
  • P/E 1 year forward6.87×
  • Forward PEG2.79×
  • Indicated annual dividend(U.S.) $1.36
  • Dividend yield4.12%
  • Trailing EPS(U.S.) $0.15
Updated March 27 1:27 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue6,4925,5635,0384,810
Total other revenue--------
Total revenue6,4925,5635,0384,810
Gross profit3,3902,8012,8772,791
Total cost of revenue3,1022,7622,1612,019
Total operating expense6,6294,7984,6773,645
Selling / general / administrative1,4401,2501,2631,143
Research & development684663375389
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,50872079231
Other operating expenses, total-105-5978663
Operating income-1377653611,165
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-914615256867
Income after tax-971408227639
Income tax, total5720729228
Net income-973412254636
Total adjustments to net income-65-64-66-66
Net income before extra. items-973412254636
Minority interest12123
Equity in affiliates-3215-6
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,038348188570
Inc. avail. to common incl. extra. items-1,038348188570
Diluted net income-1,038348188570
Dilution adjustment0000
Diluted weighted average shares1,015984920920
Diluted EPS excluding extraordinary itemsvalue per share-1.020.350.200.62
Dividends per sharevalue per share0.340.340.340.34
Diluted normalized EPSvalue per share-0.060.840.970.64